FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | May 21, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Alchymars ICM SM Private Limited has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-05-21, Argus HQ recorded an FDA Warning Letter for Alchymars ICM SM Private Limited, rated "high" severity in Argus HQ's classification: Alchymars ICM SM Private Limited — CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (2026-05-21). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- What is the most recent FDA action against Alchymars ICM SM Private Limited?
- The most recent FDA event Argus HQ has on file for Alchymars ICM SM Private Limited is dated 2026-05-21, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for Alchymars ICM SM Private Limited automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Alchymars ICM SM Private Limited is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Alchymars ICM SM Private Limited?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Alchymars ICM SM Private Limited?
- May 21, 2026. Argus HQ ingests new FDA enforcement records daily.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Alchymars ICM SM Private Limited vs Philips North America
- Alchymars ICM SM Private Limited vs Medline Industries, LP
- Alchymars ICM SM Private Limited vs Boston Scientific Corporation
- Alchymars ICM SM Private Limited vs Baxter Healthcare Corporation
- Alchymars ICM SM Private Limited vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: May 21, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Alchymars ICM SM Private Limited — FDA Enforcement History. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/alchymars-icm-sm-private-limited
"Alchymars ICM SM Private Limited — FDA Enforcement History." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/alchymars-icm-sm-private-limited.
Argus HQ Research. "Alchymars ICM SM Private Limited — FDA Enforcement History." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/alchymars-icm-sm-private-limited.
@misc{argushq_argushq_ai_company_alchymars_icm_sm_private_limited_2026,
title = {Alchymars ICM SM Private Limited — FDA Enforcement History},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/alchymars-icm-sm-private-limited},
note = {Accessed: August 29, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗